Two Years, Nine Doubles … and Our Eighth Takeover

Email
    Text size
The reported buyout of Astex Pharmaceuticals Inc. (Nasdaq: ASTX) that we told you about in yesterday's Private Briefing was confirmed - making this the eighth recommendation to result in a buyout or merger since we launched this service just two years ago.

It's also our ninth recommendation to double, triple or quadruple during that same two-year time frame.